DDS Medicines Research Ltd.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

7 documents for DDS Medicines Research Ltd.

- Research and Markets: Every Extra Day That a Drug Remains in Clinical Studies Costs the Sponsor at Least US$ 600 000 in Lost Sales.
...--Chiltern International . --ClinPhone Group Ltd . --Covance Inc. . --Clinical Trial Media . --Cust...--DDS Medicines Research Ltd. . --DxS Ltd . --Fleishman-Hillard, I...
- Business Wire
- June 24, 2005
- M&A report--February 2008.
INVESTMENT & FINANCE - Mergers and acquisitions

...Target: Dead Sea Laboratories Ltd. (Israel) . Business: Produces beauty products . A...Deal Value: $420 million . Target: DDS Medicines Reserach Ltd. (Dundee, UK) . Business: Provides heealth care research services . Acquirer: Chiltern International Inc. (...
- Los Angeles Business Journal
- March 31, 2008
- 18% Of the Population in UK is over 65 Years of Age This Accounts for 45% of Drug Dispensing.
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/rep...- DDS Medicines Research Ltd. - DxS Ltd - GeneGo Inc. - Kendle - L...
- Business Wire
- October 07, 2005

- Securities: Short sale price provisions; suspension of operation,
...FACTSET RESEARCH SYSTEMS FFFL............. FIDELITY BANKSHARES INC ...GRAFTECH INTL LTD GTK.............. GTECH HOLDINGS CORP GTY............MDC HOLDINGS INC MDCO............. MEDICINES CO MEDT............. MEDSOURCE TECHNOLOGIES MERQ.....
- FR, August 06, 2004
- Notices
- Securities and Exchange Commission
- Alnylam Grants KOKEN License to Kreutzer-Limmer Patents for the RNA Interference (RNAi) Research Products Market.
... RNAi therapeutics company, and KOKEN Co., Ltd., a leading atelocollagen company, announced today..., the creation of a major new class of medicines, known as RNAi therapeutics, is on the horizon. Sm...
- Business Wire
- October 27, 2009
- Z-Cube, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd. Sign a Licensing Agreement for the Development of an Innovative Nanotechnology Drug Delivery System for the Treatment of Pain.
... enabling the development of improved medicines for the treatment of pain," said Lorenzo Pradella,...
- Business Wire
- May 25, 2009
- Part III
...FACTSET RESEARCH SYSTEMS FFFL............. FIDELITY BANKSHARES INC ...GRAFTECH INTL LTD GTK.............. GTECH HOLDINGS CORP GTY............MDC HOLDINGS INC MDCO............. MEDICINES CO MEDT............. MEDSOURCE TECHNOLOGIES MERQ.....
- FR, August 06, 2004
- Separate parts
- Securities and Exchange Commission